Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H1AY
|
||||
Former ID |
DIB008884
|
||||
Drug Name |
AQW-051
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Novartis AG
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H22N2O
|
||||
InChI |
InChI=1S/C19H22N2O/c1-14-2-4-15(5-3-14)18-7-6-17(12-20-18)22-19-13-21-10-8-16(19)9-11-21/h2-7,12,16,19H,8-11,13H2,1H3/t19-/m0/s1
|
||||
InChIKey |
NPDLTEZXGWRMLQ-IBGZPJMESA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Neuronal acetylcholine receptor protein, alpha-7 chain | Target Info | Agonist | [532935] | |
References | |||||
Ref 523693 | ClinicalTrials.gov (NCT01474421) Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease. U.S. National Institutes of Health. | ||||
Ref 542393 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7371). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.